25 results on '"See, Raphael"'
Search Results
2. Evaluation of coronary artery calcium screening strategies focused on risk categories: The Dallas Heart Study
3. The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial
4. Achieving optimum lipid-lowering goals in patients with vascular disease
5. The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis: The Dallas Heart Study
6. Current status of risk stratification methods in acute coronary syndromes
7. Discordant effects of rosiglitazone on novel inflammatory biomarkers
8. Aortic root spontaneous echocardiographic contrast due to haemodynamic support with a percutaneous left ventricular assist device (TandemHeart)
9. Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function
10. Application of the Screening for Heart Attack Prevention and Education Task Force Recommendations to an Urban Population: Observations From the Dallas Heart Study
11. The Effect of a Disease Management Algorithm and Dedicated Postacute Coronary Syndrome Clinic on Achievement of Guideline Compliance: Results From the Parkland Acute Coronary Event Treatment Study
12. Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus
13. Abstract 356: Effect of Treatment with Rosiglitazone on High-sensitivity Cardiac Troponin Levels Among Patients with Type 2 Diabetes Mellitus
14. Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?
15. Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus.
16. The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial
17. Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment
18. Aortic root spontaneous echocardiographic contrast due to haemodynamic support with a percutaneous left ventricular assist device (TandemHeart)
19. Choice of Imaging Modality in the Assessment of Coronary Artery Disease Risk in Extreme Obesity
20. The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale
21. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: Observations from the Dallas Heart Study
22. Application of the Screening for Heart Attack Prevention and Education Task Force Recommendations to an Urban PopulationObservations From the Dallas Heart Study
23. The Effects of Rosiglitazone on Myocardial Triglyceride Content in Human Type 2 Diabetes: Results from a Six Month Double-Blind Randomized Placebo-Controlled Trial
24. The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial.
25. The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis The Dallas Heart Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.